Abstract
Colorectal cancer (CRC) is the second most death-leading cancer in the world. The development of CRC is closely related to the hedgehog signaling pathway. The abnormal activation of the pathway will initiate the binding of Sonic Hedgehog (Shh) to Ptch1 that can trigger the growth of abnormal cells that cause CRC. Traditional Chinese Medicine (TCM) compounds were used to inhibit Shh through structure-based pharmacophore design. This research was started by finding the pharmacophore feature of Shh, continued with docking simulation of Shh with TCM compounds. The best three TCM compounds, which are TCM-8941, TCM-28794 and TCM-32808, give the best ligand interaction and have the lowest Gibbs free binding energy. They also have good pharmacological properties that have been analyzed by using Toxtree v2.6.13, SwissADME and admetSAR. For further research, these TCM compounds may be used as drug candidates in colorectal cancer.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
